BSG – ESD Interest Group
Thursday, 12 December 2013 09:54
- To develop and support training & service standards in Endoscopic Submucosal Dissection of the GI tract.
- To encourage participation in UK multicenter research on ESD of the GI tract
Core Development group:
Prof Pradeep Bhandari (Chair)
Dr Sunil Dolwani (Secretary)
Dr Noriko Suzuki (Technical Lead)
Membership - Membership of the group is open to members of the BSG who can demonstrate their ability, motivation and local/regional support for the development of ESD in the UK. Members are expected to participate in workshops and will benefit from access to international and national faculty as part of the workshops as well as participation in discussion regarding pathways for referral, technical aspects and regional networks for ESD in the UK.
Annual program of the BSG- ESDIG – The Group is supported by the Endoscopy committee of the BSG and aims to continue workshops at least twice a year in the UK with invited International faculty, live case demonstration, hands on time on animal models to assist and facilitate learning ESD techniques in a safe environment. Workshops include a discussion forum for local experience, technical and logistical tips and tricks, governance issues, UK regulation related to ESD as well as training of assistants and nurses and are generously supported by Industry partners. Members are encouraged to bring a nominated endoscopy nurse to learn from our Nurse faculty and assist them in local service set up. Workshops are usually limited to small numbers and early application is advised. Previous International Workshop faculty have included – Dr. Yutaka Saito & Dr. Takashi Toyonaga. Future plans include development of a structured individualized training program for members in collaboration with National & International colleagues and assistance with facilitation of International fellowship support through links via the core development group.
Decontamination Alert: August 2013
Thursday, 22 August 2013 08:15
Choice Framework for local Policy and Procedures 01-06: Decontamination of flexible endoscopes details that manufacturer's instructions must be followed at all times when using an Endoscope Washer Disinfector (EWD), and selecting chemicals for use.
All units are asked to check that the chemicals (detergents and disinfectants) used in their EWDs are those tested by the machine manufacturer at the type-test stage with supporting evidence of efficacy. Under no circumstances should a chemical (i.e. disinfectant) be used that was not included in the type test data for that machine, this supports the need to follow manufacturer's instructions, as non-type tested chemicals may damage the internal mechanics of the EWD, therefore a possible risk to patients may occur.
If you are unsure which chemicals are recommended in your EWD please speak to your manufacturer requesting information specifically on 'type tested' chemicals.
Dr Helen Griffiths
Nurse Consultant Gastroenterology
Decontamination representative BSG Endoscopy Committee
On behalf of the Professional Expert Communications Forum: Decontamination of Medical Devices.
- Download alert [ 21 Kb ]
Meeting the Demand for Endoscopy Services
Monday, 30 April 2012 11:12
Steve Hughes, BSG Vice-President Endoscopy & Roland Valori National Clinical Director for Endoscopy
There will be a 75% increase (on 2010/11 activity) in lower GI endoscopy demand in England in the next four years, on top of the 50% increase in activity achieved in the last four years. This extra demand arises from screening and symptomatic work. Most services have just been coping with increasing demand in recent years, but waiting lists initiatives remain common place and a few sites have perpetually long waits. Long waits is the most common reason sites struggle to maintain JAG accreditation. There is an urgent need to do things differently to respond to the increase in demand and to make 'just coping' a thing of the past. Learning from sites that maintain low waits indicates there are two key factors that determine how well a service keeps in control of its demand: effective planning and high productivity.
In anticipation of the increasing demand for endoscopy, and appreciation of the pressures endoscopy teams are under, the JAG, in collaboration with the Bowel Cancer Screening Programme, is delivering a series of ten workshops throughout England to help endoscopy teams plan better and be more productive. The principal objective of the workshops is to enable teams to present more effective business plans to their trust boards. They are aimed at the medical and nurse lead, and their manager, and a representative of their PCT. They will be delivered in the next six months and be led by Roland Valori, NCD for endoscopy. You are strongly encouraged to attend. For more details please visit the JAG website: www.thejag.org.uk
Reducing risk of harm caused by bowel cleansing medication
Tuesday, 08 March 2011 16:39
This resource is one of a series produced by the Medicines Use and Safety Division of the East and South East England Specialist Pharmacy Services. These resources aim to support NHS organisations and practitioners from all sectors of care in implementing and assuring medication-related requirements published by the NPSA (Rapid Response Report RRR012: 'Reducing risk of harm from oral bowel cleansing solutions') to ensure that they are embedded in practice over time: a do-once-and-share approach.
- Download resource [ 256 kb ]
Statement on Entonox and Fitness to Drive
Tuesday, 06 July 2010 09:01
The BSGE has recently received an enquiry into the use of Entonox and fitness to drive. Entonox (50% nitrous oxide, 50% oxygen, manufactured by BOC) is mainly used in obstetric units and by the ambulance service, but its analgesic and sedative properties with rapid onset and offset make it a potentially attractive agent in patients having colonoscopy and it is already in use in many units. A number of publications in the 1990s showed that it is safe and effective, with reduced discomfort and nausea compared to IV agents and allows earlier discharge from the recovery unit. It is perhaps surprising that it is not more widely used.
As for the question of fitness to drive: the recently revised product licence states that patients are fit to drive a vehicle (or operate machinery) after only 30 minutes. Used in combination with a rapidly acting bowel cleansing agent, this could mean that for patients whose colonoscopy is to be done mid-week, only half a day away from work is required – a major advantage for the self-employed. A pdf file, "Entonox: Information for the User" is available from BOC (and on the BSG website)
Alistair McNair, Secretary BSG Endoscopy
- BOC Entonox Product Guide [ 44 Kb ]
Page 2 of 3